Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $375.00 at Jefferies Financial Group

Intuitive Surgical (NASDAQ:ISRG) had its target price raised by Jefferies Financial Group from $365.00 to $375.00 in a research report report published on Friday morning, Benzinga reports. Jefferies Financial Group currently has a hold rating on the medical equipment provider’s stock.

Several other equities analysts have also recently issued reports on ISRG. Stifel Nicolaus boosted their target price on Intuitive Surgical from $420.00 to $430.00 and gave the company a buy rating in a research note on Monday, April 8th. Royal Bank of Canada boosted their price target on shares of Intuitive Surgical from $400.00 to $432.00 and gave the company an outperform rating in a research report on Wednesday, January 24th. Piper Sandler raised their price objective on shares of Intuitive Surgical from $325.00 to $425.00 and gave the stock an overweight rating in a report on Wednesday, January 24th. Barclays upped their target price on Intuitive Surgical from $385.00 to $430.00 and gave the stock an overweight rating in a report on Thursday, January 25th. Finally, Mizuho raised their target price on Intuitive Surgical from $350.00 to $390.00 and gave the company a neutral rating in a research note on Thursday, January 25th. Five equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of Moderate Buy and an average target price of $396.17.

Intuitive Surgical Stock Up 0.7 %

NASDAQ:ISRG opened at $368.93 on Friday. The firm has a market capitalization of $130.77 billion, a P/E ratio of 66.59, a P/E/G ratio of 5.69 and a beta of 1.36. The company has a fifty day moving average of $386.57 and a 200 day moving average of $344.41. Intuitive Surgical has a 52 week low of $254.85 and a 52 week high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. The company had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. Intuitive Surgical’s revenue for the quarter was up 11.5% on a year-over-year basis. During the same period in the prior year, the business posted $1.00 earnings per share. As a group, analysts anticipate that Intuitive Surgical will post 4.93 EPS for the current year.

Insiders Place Their Bets

In other news, EVP Myriam Curet sold 4,318 shares of the stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $370.15, for a total transaction of $1,598,307.70. Following the sale, the executive vice president now owns 189 shares in the company, valued at $69,958.35. The transaction was disclosed in a filing with the SEC, which is available at this link. In other Intuitive Surgical news, Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction dated Friday, January 26th. The stock was sold at an average price of $370.20, for a total value of $740,400.00. Following the completion of the transaction, the director now owns 25,319 shares of the company’s stock, valued at approximately $9,373,093.80. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Myriam Curet sold 4,318 shares of the firm’s stock in a transaction dated Friday, January 26th. The shares were sold at an average price of $370.15, for a total transaction of $1,598,307.70. Following the sale, the executive vice president now directly owns 189 shares in the company, valued at approximately $69,958.35. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 248,418 shares of company stock valued at $95,927,097. Insiders own 0.80% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ISRG. OFI Invest Asset Management purchased a new stake in Intuitive Surgical during the 3rd quarter valued at $25,000. Baystate Wealth Management LLC grew its holdings in shares of Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 45 shares during the period. MCF Advisors LLC increased its position in Intuitive Surgical by 108.1% during the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after acquiring an additional 40 shares during the last quarter. Headinvest LLC bought a new position in Intuitive Surgical in the third quarter valued at about $28,000. Finally, Able Wealth Management LLC purchased a new position in Intuitive Surgical in the fourth quarter worth about $28,000. Institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.